Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aldo–Keto Reductase AKR1C1–AKR1C4: Functions, Regulation, and Intervention for Anti-cancer Therapy
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-03-14
DOI
10.3389/fphar.2017.00119
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human 3 -hydroxysteroid dehydrogenase type 3: structural clues of 5 -DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth
- (2016) B. Zhang et al. BIOCHEMICAL JOURNAL
- Pyrithione-based ruthenium complexes as inhibitors of aldo–keto reductase 1C enzymes and anticancer agents
- (2016) Jakob Kljun et al. DALTON TRANSACTIONS
- Osteoblasts promote castration-resistant prostate cancer by altering intratumoral steroidogenesis
- (2016) Malin Hagberg Thulin et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Overexpression of AKR1C3 significantly enhances human prostate cancer cells resistance to radiation
- (2016) Shao-Qian Sun et al. Oncotarget
- Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway
- (2016) Yiying Wang et al. Oncotarget
- Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression
- (2016) Ailin Zhang et al. Hormones & Cancer
- Intracrine Androgens Enhance Decidualization and Modulate Expression of Human Endometrial Receptivity Genes
- (2016) Douglas A. Gibson et al. Scientific Reports
- Pharmacokinetic interactions of breast cancer chemotherapeutics with human doxorubicin reductases
- (2015) Jakub Hofman et al. BIOCHEMICAL PHARMACOLOGY
- Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN Loss
- (2015) Ting Zhong et al. BIOMEDICINE & PHARMACOTHERAPY
- In vitro inhibition of AKR1Cs by sulphonylureas and the structural basis
- (2015) Yining Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Screening baccharin analogs as selective inhibitors against type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)
- (2015) Tianzhu Zang et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Important roles of the AKR1C2 and SRD5A1 enzymes in progesterone metabolism in endometrial cancer model cell lines
- (2015) Maša Sinreih et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Ruthenium complexes as inhibitors of the aldo–keto reductases AKR1C1–1C3
- (2015) Katja Traven et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2α biosynthesis and action in ovarian endometriosis tissue and in model cell lines
- (2015) Maša Sinreih et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer
- (2015) Antonia Wenners et al. International Journal of Clinical Oncology
- The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells
- (2015) Lingling Fan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- 11β-Prostaglandin F2α, a bioactive metabolite catalyzed by AKR1C3, stimulates prostaglandin F receptor and induces slug expression in breast cancer
- (2015) Tomomi Yoda et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer
- (2015) Cong Li et al. ONCOLOGY RESEARCH
- Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
- (2014) Toshiyuki Matsunaga et al. ANTI-CANCER DRUGS
- Morpholylureas are a new class of potent and selective inhibitors of the type 5 17-β-hydroxysteroid dehydrogenase (AKR1C3)
- (2014) Jack U. Flanagan et al. BIOORGANIC & MEDICINAL CHEMISTRY
- AKR1C3 overexpression may serve as a promising biomarker for prostate cancer progression
- (2014) Yuantong Tian et al. Diagnostic Pathology
- Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study
- (2014) Yohann Loriot et al. INVESTIGATIONAL NEW DRUGS
- Elevated Expression of AKR1C3 Increases Resistance of Cancer Cells to Ionizing Radiation via Modulation of Oxidative Stress
- (2014) Wei Xiong et al. PLoS One
- Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C3
- (2014) Jakub Hofman et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer
- (2014) Yarong Diana Yin et al. Frontiers in Oncology
- Short and long term gene expression variation and networking in human proximal tubule cells when exposed to cadmium
- (2013) Scott H Garrett et al. BMC Medical Genomics
- The E3 Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity
- (2013) Jianfei Qi et al. CANCER CELL
- Aldo-keto reductase 1C3 may be a new radioresistance marker in non-small-cell lung cancer
- (2013) L Xie et al. CANCER GENE THERAPY
- Panax ginseng polysaccharide induces apoptosis by targeting Twist/AKR1C2/NF-1 pathway in human gastric cancer
- (2013) Cong Li et al. CARBOHYDRATE POLYMERS
- Steroidogenic Enzyme AKR1C3 Is a Novel Androgen Receptor-Selective Coactivator that Promotes Prostate Cancer Growth
- (2013) M. Yepuru et al. CLINICAL CANCER RESEARCH
- Synthesis and structure–activity relationships for 1-(4-(piperidin-1-ylsulfonyl)phenyl)pyrrolidin-2-ones as novel non-carboxylate inhibitors of the aldo-keto reductase enzyme AKR1C3
- (2013) Daniel M. Heinrich et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Clinical implications of aldo-keto reductase family 1 member C3 and its relationship with lipocalin 2 in cancer of the uterine cervix
- (2013) Chih-Hsien Wu et al. GYNECOLOGIC ONCOLOGY
- Development of Potent and Selective Indomethacin Analogues for the Inhibition of AKR1C3 (Type 5 17β-Hydroxysteroid Dehydrogenase/Prostaglandin F Synthase) in Castrate-Resistant Prostate Cancer
- (2013) Andy J. Liedtke et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of aldo–keto reductase family 1 (AKR1) enzymes in human steroid metabolism
- (2013) Tea Lanišnik Rižner et al. STEROIDS
- Role of aldo-keto reductases and other doxorubicin pharmacokinetic genes in doxorubicin resistance, DNA binding, and subcellular localization
- (2012) Allan D Heibein et al. BMC CANCER
- Methylation of the KEAP1 gene promoter region in human colorectal cancer
- (2012) Naoyuki Hanada et al. BMC CANCER
- Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers
- (2012) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Polymorphisms in AKR1C4 and HSD3B2 and differences in serum DHEAS and progesterone are associated with paranoid ideation during mania or hypomania in bipolar disorder
- (2012) Anette G.M. Johansson et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- 3-(3,4-Dihydroisoquinolin-2(1H)-ylsulfonyl)benzoic Acids: Highly Potent and Selective Inhibitors of the Type 5 17-β-Hydroxysteroid Dehydrogenase AKR1C3
- (2012) Stephen M. F. Jamieson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Adaptation or selection—mechanisms of castration-resistant prostate cancer
- (2012) Yang Zong et al. Nature Reviews Urology
- Discovery of substituted 3-(phenylamino)benzoic acids as potent and selective inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3)
- (2011) Adegoke O. Adeniji et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- PTHrP stimulates prostate cancer cell growth and upregulates aldo–keto reductase 1C3
- (2011) Tracy M. Downs et al. CANCER LETTERS
- Transforming growth factor β1 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells
- (2011) Xunxian Liu et al. CARCINOGENESIS
- Potential Prostate Cancer Drug Target: Bioactivation of Androstanediol by Conversion to Dihydrotestosterone: Figure 1.
- (2011) James L. Mohler et al. CLINICAL CANCER RESEARCH
- AKR1C4 gene variant associated with low euthymic serum progesterone and a history of mood irritability in males with bipolar disorder
- (2011) Anette G.M. Johansson et al. JOURNAL OF AFFECTIVE DISORDERS
- Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
- (2011) Masaki Shiota et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- New and emerging agents for the treatment of castration-resistant prostate cancer
- (2011) Celestia S. Higano et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Evidence of Limited Contributions for Intratumoral Steroidogenesis in Prostate Cancer
- (2010) J. Hofland et al. CANCER RESEARCH
- Progestins as inhibitors of the human 20-ketosteroid reductases, AKR1C1 and AKR1C3
- (2010) N. Beranič et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors
- (2010) Ossama El-Kabbani et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- New cyclopentane derivatives as inhibitors of steroid metabolizing enzymes AKR1C1 and AKR1C3
- (2009) Bogdan Štefane et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Correlation of binding constants and molecular modelling of inhibitors in the active sites of aldose reductase and aldehyde reductase
- (2008) Vincenzo Carbone et al. BIOORGANIC & MEDICINAL CHEMISTRY
- AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids
- (2008) Lucie Škarydová et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Derivatives of pyrimidine, phthalimide and anthranilic acid as inhibitors of human hydroxysteroid dehydrogenase AKR1C1
- (2008) P. Brožič et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification
- (2008) Oleg A. Barski et al. DRUG METABOLISM REVIEWS
- Steroidal lactones as inhibitors of 17β-hydroxysteroid dehydrogenase type 5: Chemical synthesis, enzyme inhibitory activity, and assessment of estrogenic and androgenic activities
- (2008) Patrick Bydal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inactivation of the anticancer drugs doxorubicin and oracin by aldo–keto reductase (AKR) 1C3
- (2008) Romana Novotna et al. TOXICOLOGY LETTERS
- Mechanisms mediating androgen receptor reactivation after castration
- (2008) Xin Yuan et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- An indomethacin analogue, N-(4-chlorobenzoyl)-melatonin, is a selective inhibitor of aldo-keto reductase 1C3 (type 2 3α-HSD, type 5 17β-HSD, and prostaglandin F synthase), a potential target for the treatment of hormone dependent and hormone independent malignancies
- (2007) Michael C. Byrns et al. BIOCHEMICAL PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now